SCATENA, CRISTIAN
 Distribuzione geografica
Continente #
NA - Nord America 7.297
AS - Asia 3.386
EU - Europa 2.982
SA - Sud America 654
Continente sconosciuto - Info sul continente non disponibili 321
AF - Africa 215
OC - Oceania 10
Totale 14.865
Nazione #
US - Stati Uniti d'America 7.092
IT - Italia 1.464
SG - Singapore 1.218
CN - Cina 795
BR - Brasile 534
HK - Hong Kong 532
VN - Vietnam 341
SE - Svezia 325
DE - Germania 276
GB - Regno Unito 191
FR - Francia 133
CA - Canada 129
BG - Bulgaria 128
IN - India 104
FI - Finlandia 96
CI - Costa d'Avorio 74
JP - Giappone 68
RU - Federazione Russa 68
NL - Olanda 62
TR - Turchia 53
AT - Austria 52
BD - Bangladesh 52
PL - Polonia 39
MX - Messico 37
SN - Senegal 36
AR - Argentina 35
KR - Corea 34
ES - Italia 30
MA - Marocco 25
IQ - Iraq 24
ID - Indonesia 22
PK - Pakistan 20
SA - Arabia Saudita 20
ZA - Sudafrica 20
BE - Belgio 18
EC - Ecuador 17
NG - Nigeria 17
CO - Colombia 16
CL - Cile 14
CZ - Repubblica Ceca 14
VE - Venezuela 12
TW - Taiwan 11
UA - Ucraina 11
UZ - Uzbekistan 11
CH - Svizzera 10
AU - Australia 9
IE - Irlanda 9
JO - Giordania 9
KE - Kenya 9
JM - Giamaica 8
PH - Filippine 8
PY - Paraguay 8
AZ - Azerbaigian 7
CR - Costa Rica 7
DZ - Algeria 7
EG - Egitto 7
GR - Grecia 7
LT - Lituania 7
PE - Perù 7
RO - Romania 7
PT - Portogallo 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
KZ - Kazakistan 5
LB - Libano 5
MY - Malesia 5
OM - Oman 5
PA - Panama 5
TH - Thailandia 5
DK - Danimarca 4
HN - Honduras 4
HU - Ungheria 4
IL - Israele 4
LV - Lettonia 4
LY - Libia 4
TN - Tunisia 4
AL - Albania 3
AM - Armenia 3
BB - Barbados 3
BO - Bolivia 3
BZ - Belize 3
ET - Etiopia 3
KG - Kirghizistan 3
MK - Macedonia 3
PS - Palestinian Territory 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
CY - Cipro 2
DO - Repubblica Dominicana 2
EE - Estonia 2
EU - Europa 2
GE - Georgia 2
MD - Moldavia 2
MM - Myanmar 2
NP - Nepal 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
BA - Bosnia-Erzegovina 1
BJ - Benin 1
Totale 14.528
Città #
Ashburn 750
Singapore 689
San Jose 612
Dallas 597
Hong Kong 519
Santa Clara 406
Fairfield 390
Woodbridge 287
Chandler 277
Pisa 246
Houston 224
Seattle 211
Shanghai 184
New York 181
Beijing 157
Wilmington 152
Cambridge 148
Los Angeles 145
Milan 143
Ann Arbor 130
Sofia 125
Lucca 112
Council Bluffs 109
Florence 109
Boardman 103
Munich 95
Frankfurt am Main 93
Ho Chi Minh City 88
Hanoi 87
London 83
Abidjan 74
Princeton 74
Rome 63
Lauterbourg 60
Cascina 59
Tokyo 59
Lawrence 58
São Paulo 51
Medford 49
Serra 48
Hefei 43
Vienna 43
Toronto 42
Turku 41
Atlanta 37
Buffalo 37
Dakar 36
Ottawa 36
Redondo Beach 33
Boulder 31
Des Moines 29
Istanbul 29
Ogden 29
Helsinki 28
Orem 28
Chicago 27
Dong Ket 27
Warsaw 27
Seoul 25
Amsterdam 24
Dearborn 24
Chennai 23
Denver 20
Nanjing 19
Redwood City 19
Haiphong 18
Phoenix 18
San Francisco 18
Vicopisano 18
Paris 17
Lagos 16
Lappeenranta 16
Marseille 16
Bremen 15
Brussels 15
Bari 14
Capannori 14
Fuzhou 14
Genoa 14
Mexico City 14
Nuremberg 14
San Diego 14
Brooklyn 13
Casablanca 13
Guangzhou 13
Manchester 13
Pontedera 13
Baltimore 12
Changsha 12
Düsseldorf 12
Montreal 12
Philadelphia 12
Poplar 12
Quanzhou 12
Rio de Janeiro 12
Pune 11
Baghdad 10
Brasília 10
Da Nang 10
Nanchang 10
Totale 9.281
Nome #
Macrophage Polarization and Prognostic Implications in Glioblastoma 326
CD80/CD163 macrophage signature identifies high-risk glioblastoma patients 299
Correction to: Association of XRCC3 rs1799794 polymorphism with survival of glioblastoma multiforme patients treated with combined radio-chemotherapy 268
Association of XRCC3 rs1799794 polymorphism with survival of glioblastoma multiforme patients treated with combined radio-chemotherapy 256
Doxycycline, an Inhibitor of Mitochondrial Biogenesis, Effectively Reduces Cancer Stem Cells (CSCs) in Early Breast Cancer Patients: A Clinical Pilot Study 252
Role of circulating endothelial progenitor cells in the reparative mechanisms of stable ischemic myocardium 250
Endothelial progenitor cells recruitment correlate with coronary artery disease severity 249
Cancer astrocytes have a more conserved molecular status in long recurrence free survival (RFS) IDH1 wild-type glioblastoma patients: New emerging cancer players 237
MicroRNAs distribution in different phenotypes of Aortic Stenosis 225
The inherent molecular stigma in normal breast tissue of BRCA1/2 gene mutation carriers: TC1 and SYNGR2 genes involvement in neoplastic transformatio 221
Circulating Cell-Free DNA in Renal Cell Carcinoma: The New Era of Precision Medicine 219
Heterogeneity of Hormone Receptors and HER2 in Breast Cancer Cutaneous Metastases: An Institutional Experience 211
Circulating endothelial progenitor cells are actively involved in the reparative mechanisms of stable ischemic myocardium 210
The integrated value of sST2 and global longitudinal strain in the early stratification of patients with severe aortic valve stenosis: a translational imaging approach 207
Toward a regional digital pathology network in Tuscany: current status and implementation roadmap 204
Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients 200
Sparc-like protein 1 is a new marker of human glioma progression 198
Endothelial progenitor cell homing in human myocardium in patients with coronary artery disease 196
A mouse mammary tumor virus env-like exogenous sequence is strictly related to progression of human sporadic breast carcinoma 195
Comprehensive Diagnostic and Therapeutic Approaches for Estrogen Receptor-Low Breast Cancer: A Multidisciplinary Perspective From Oncologists and Pathologists 193
CD57 and γδ T‐cell receptor expression in nodal metastatic spread of melanoma 192
IDH1 mutation is detectable in plasma cell-free DNA and is associated with survival outcome in glioma patients 188
ANKRd44 gene silencing: A putative role in trastuzumab resistance in HER2-like breast cancer 183
Diagnosis and treatment monitoring in breast cancer: how liquid biopsy can support patient management 179
Old and New Systemic Immune-Inflammation Indexes Are Associated with Overall Survival of Glioblastoma Patients Treated with Radio-Chemotherapy 177
Male secretory breast cancer: case in a 6-year-old boy with a peculiar gene duplication and review of the literature 177
Endothelial progenitor cells: An appraisal of relevant data from bench to bedside 174
Tumour stroma characterization for the clinical stratification of HR+/HER2- breast cancer 172
Pre-operative management of Pleomorphic and florid lobular carcinoma in situ of the breast: Report of a large multi-institutional series and review of the literature 171
Review in translational cardiology: Micrornas and myocardial fibrosis in aortic valve stenosis, a deep insight on left ventricular remodeling 170
Circulating tumor cells detection and counting in uveal melanomas by a filtration-based method 170
Disseminated bone metastases from occult thyroid cancer effectively treated with debulking surgery and a single dosimetry-guided administration of radioiodine. 169
IOERT in Breast Cancer: Results of Ten-Year Follow-Up in an Italian Experience Confirm High Local Recurrence Rate 166
Micro‑RNA‑21 (biomarker) and global longitudinal strain (functional marker) in detection of myocardial fibrotic burden in severe aortic valve stenosis: a pilot study 161
Molecular characterization of low grade and high grade bladder cancer 161
Germline investigation in male breast cancer of DNA repair genes by next-generation sequencing 159
Detection of circulating tumor cells in patients with Adrenocortical carcinoma: A Monocentric preliminary study 157
Dabrafenib and Trametinib prolong coagulation through the inhibition of tissue factor in BRAFv600e mutated melanoma cells in vitro 154
Reply letter to Dr. Xu et al. on role of circulating endothelial progenitor cells in the reparative mechanisms of stable ischemic myocardium 150
Impact of recurrence pattern in patients undergoing a second surgery for recurrent glioblastoma 150
Decipher the glioblastoma microenvironment: The first milestone for new groundbreaking therapeutic strategies 149
Mouse mammary tumor virus (MMTV) - like exogenous sequences are associated with sporadic but not hereditary human breast carcinoma 147
Thrombophilic status may predict prognosis in patients with metastatic BRAFV600-mutated melanoma who are receiving BRAF inhibitors 143
Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells 142
Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide survey 141
The Prognostic Impact of Gender, Therapeutic Strategies, Molecular Background, and Tumor-Infiltrating Lymphocytes in Glioblastoma: A Still Unsolved Jigsaw 140
Soft Graspers for Safe and Effective Tissue Clutching in Minimally Invasive Surgery 140
MOLECULAR ANALYSIS OF PRIMARY MUCINOUS CYSTOADENOCARCINOMA OF THE BREAST: A CASE REPORT (Section: Breast Pathology) 139
Investigating molecular alterations to profile short- and long-term recurrence-free survival in patients with primary glioblastoma 138
Intralymphatic histiocytosis: Cutaneous nodules and metal implants 138
Rhabdomyosarcoma of the skin resembling carcinosarcoma: Report of a case and literature review 136
Is it time to consider the Androgen receptor as a therapeutic target in breast cancer? 136
Immunohistochemistry for thymidine kinase-1 (Tk1): A potential tool for the prognostic stratification of breast cancer patients 136
MammaTyper®: molecular predictor of response to neoadjuvant therapy in HER2-positive breast cancer 134
Androgen receptor expression inversely correlates with histological grade and N stage in ER+/PgRlow male breast cancer 134
Human saliva as route of inter-human infection for mouse mammary tumor virus 134
Surgical outcome and molecular pattern characterization of recurrent glioblastoma multiforme: A single-center retrospective series 130
Molecular profiling of microinvasive breast cancer microenvironment progression 127
A human MMTV-like betaretrovirus linked to breast cancer has been present in humans at least since the copper age 126
Cutaneous nodules and erythematous plaques on the extremities 125
Prediction of response to neoadjuvant chemotherapy in HER2 positive breast cancer by MammaTyper® 125
From Tuscany to Vienna: Paolo Mascagni's anatomic models in the Josephinum 124
New insights in the expression of stromal caveolin 1 in breast cancer spread to axillary lymph nodes 121
Jessner-Kanof disease: Two effective and sure therapeutic options 120
Human sporadic breast carcinoma histotypes driven by the Human Betaretrovirus homologous to Mouse Mammary Tumor Virus 119
Use of MammaTyper® in predicting response to neoadjuvant therapy in HER2-positive breast cancer 117
New insights in the clinical and translational relevance of miR483-5p in adrenocortical cancer 117
Biomarkers for precision immunotherapy in the metastatic setting: Hope or reality? 117
Bedaquiline, an FDA-approved drug, inhibits mitochondrial ATP production and metastasis in vivo, by targeting the gamma subunit (ATP5F1C) of the ATP synthase 116
PROMs in post-mastectomy care: Patient self-reports (BREAST-Q™) as a powerful instrument to personalize medical services 113
Molecular Mechanisms, Biomarkers and Emerging Therapies for Chemotherapy Resistant TNBC 112
BAG2, MAD2L1, and MDK are cancer-driver genes and candidate targets for novel therapies in malignant pleural mesothelioma 112
Insights from Multigene Panel Sequencing and Comparative Analysis of Metaplastic Carcinoma of the Breast 108
Renal metastasis from pulmonary adenocarcinoma: The pathologist's approach to an uncommon finding: Case report and review of the literature 107
Patologia della mammella 106
A budget impact analysis of the VENTANA PD-L1 SP142 immunohistochemistry assay versus the Dako PD-L1 IHC 22C3 assay in patients with advanced or metastatic triple-negative breast cancer treated with atezolizumab in combination with nab-paclitaxel 103
Follicular melanoma—A rare entity: First description of an association with a nevus 102
Fibrin associated large B-cell lymphoma accidentally identified in a breast implant capsule: a molecular report of a rare entity 102
Recent Advances in Cancer Plasticity: Cellular Mechanisms, Surveillance Strategies, and Therapeutic Optimization 101
Shedding light on PRAME expression in dysplastic nevi: a cohort study 100
Prediction of response to neoadjuvant chemotherapy in HER2 positive breast cancer by MammaTyper® 98
null 95
Ultra-High Frequency Ultrasound in Melanoma Management: A New Combined Ultrasonographic–Histopathological Approach 94
Myocardial fibrosis and microRNA-21 expression in patients with severe aortic valve stenosis and preserved ejection fraction: a 2D speckle tracking echocardiography, tissutal and plasmatic study 89
Cutaneous Melanoma Classification: The Importance of High-Throughput Genomic Technologies 89
Special issue: Molecular biomarkers in solid tumors 88
null 80
null 78
Molecularly defined tumour microenvironment ecosystems enhance prognostic stratification in low- and intermediate-risk prostate cancer 76
Immunohistochemistry is highly sensitive and specific for the detection of NRASQ61R mutation in melanoma 71
Assessment of estrogen receptor low positive status in breast cancer: Implications for pathologists and oncologists 71
Is it TIME for the clinical stratification of HR+/HER2- breast cancer? 66
null 65
Antibody-Based Multiplex Image Analysis: Standard Analytical Workflows and Artificial Intelligence Tools for Pathologists 64
Italian guidelines for age range and test interval in breast cancer screening programmes: GRADE-ADOLOPMENT of the European guidelines 60
Editorial: Metabolic reprogramming in breast cancer 60
Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial Intelligence 58
Liquid biopsy in breast cancer: Redefining precision medicine 55
MTClin: Integrating MammaTyper® to predict neoadjuvant therapy response in HER2+ breast cancer 54
Circulating free PSA in breast cancer patients: is it a reliable biomarker? 53
Totale 14.437
Categoria #
all - tutte 42.114
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.114


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022722 0 29 16 36 146 103 44 25 47 25 64 187
2022/20231.115 120 145 78 52 111 138 15 92 244 6 103 11
2023/2024879 55 67 99 154 93 136 57 24 17 42 65 70
2024/20253.247 54 104 33 197 306 388 316 162 325 349 317 696
2025/20265.273 315 476 692 547 567 338 674 304 320 688 174 178
2026/20271.147 318 829 0 0 0 0 0 0 0 0 0 0
Totale 14.865